Synbio Technologies

Synbio Technologies is a long-established, private synthetic biology service and product company catering to the research and therapeutic development markets. Its core business model revolves around providing outsourced R&D services, including custom gene synthesis, oligonucleotide production, genome editing libraries, and antibody development, supported by a suite of proprietary vectors and bioinformatics tools. The company is leveraging the growth in precision gene editing, oligonucleotide therapeutics, and AI-designed proteins to expand its offerings. It appears to be a revenue-generating entity serving a global client base from its headquarters in Monmouth Junction, New Jersey.

Integrated synthetic biology platform encompassing high-throughput DNA/RNA synthesis, proprietary vector systems (ProXpress), gene editing library construction, virus packaging, and antibody discovery/engineering services, supported by bioinformatics tools.

Operates in a crowded synthetic biology services market competing against giants like Thermo Fisher Scientific and Danaher (via IDT), as well as pure-play firms like GenScript, Twist Bioscience, and Eurofins. Differentiation is based on breadth of services, proprietary tools (e.g., ProXpress vectors), turnaround time, and price.